Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Perception ; 30(11): 1363-73, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11768489

RESUMO

Carryover of stimuli in sequential judgments was studied for a visual assessment task involving estimation of the percentage cover of black circles on a white image. Seven image types with different levels of cover density were arranged in a sequentially balanced design in which each image type was preceded the same number of times by all image types. In the absence of carryover, when images were preceded by images with the same cover density, the response scores were well fitted by a power function of percentage cover with a mean exponent of 0.73 over subjects. Carryover took the form of an assimilation, so that the cover estimate for a target image was generally higher when preceded by an image with higher cover, and lower when preceded by an image with lower cover. However, the magnitude of the carryover effect showed little evidence of increasing with difference in cover between successive images. Nonparametric and parametric methods for testing for carryover are presented. The need for development of psychological models to explain the proposed statistical models is discussed.


Assuntos
Discriminação Psicológica/fisiologia , Modelos Estatísticos , Adolescente , Adulto , Análise de Variância , Feminino , Humanos , Análise dos Mínimos Quadrados , Modelos Lineares , Masculino , Variações Dependentes do Observador , Psicofísica , Estatísticas não Paramétricas
2.
Br J Clin Pharmacol ; 4(5): 605-9, 1977 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20919

RESUMO

1. Using the same technique of administering drugs by intermittent positive-pressure ventilation as used in previous studies a source of contamination of solutions nebulized was discovered. This was rectified by using a new ventilator and completely separate patient circuits for each solution nebulized. 2 Salbutamol 0.5% and 0.25% solutions achieved the same degree of bronchodilatation, but there was a significantly greater increase in heart rate produced by salbutamol 0.5%. 3 Rimiterol 0.5% and salbutamol 0.25% produced similar peak mean improvements in FEV and also induced the same degree of tachycardia, but the duration of these effects were significantly shorter in the case of rimiterol. 4 The sustained degree of bronchodilatation achieved by salbutamol 0.25% could not be mirrored by giving two doses of rimiterol 0.5%, the second dose 2 h after the first. 5 Rimiterol 0.5% induced a degree of tachycardia which was similar in peak effect to that observed after salbutamol 0.25%. However, in the controls the second dose of rimiterol, given 2 h after the first, was responsible for only a small increase in heart rate which was not significantly different than that after saline in the other three treatment groups.


Assuntos
Albuterol/farmacologia , Catecóis/farmacologia , Respiração com Pressão Positiva Intermitente/instrumentação , Piperidinas/farmacologia , Respiração com Pressão Positiva/instrumentação , Adulto , Idoso , Albuterol/administração & dosagem , Asma/fisiopatologia , Feminino , Volume Expiratório Forçado , Frequência Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Piperidinas/administração & dosagem , Fatores de Tempo
4.
Br J Clin Pharmacol ; 3(1): 151-5, 1976 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-788738

RESUMO

1 Inhaled salmefamol, in doses of 100 mug and 200 mug has been compared with inhaled salbutamol, in a dose of 200 mug, and with placebo in patients with airways obstruction. 2 Both salmefamol and salbutamol are potent bronchodilators with a signficantly superior action over placebo at all times up to 8 h after treatment. 3 The mean peak percentage increases in FEV produced by the three active preparations were similar. The decline from peak values was significantly slower with salmefamol than with salbutamol. Neither drug produced tachycardia.


Assuntos
Obstrução das Vias Respiratórias/tratamento farmacológico , Albuterol/uso terapêutico , Etanolaminas/uso terapêutico , Adolescente , Adulto , Doença Crônica , Ensaios Clínicos como Assunto , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Placebos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...